MORE blood pressure pills recalled over carcinogen fears: 4th round of losartan pulled from US market as the global drug shortage drags on for almost a YEAR
Last summer it emerged drugs made in China and India, and dispatched across the world were contaminated with carcinogens NMBA, NMDA, and NDEA The scandal was kept under wraps for a year before health officials finally acknowledged the contamination It affected valsartan, irbesartan and losartan, some of the most widely-used blood pressure drugs More than two million people had been exposed, half of whom were in the US On Thursday, Torrent Pharmaceuticals recalled more losartanBy Mia De Graaf Health Editor For Dailymail.com
Published: 14:15 BST, 19 April 2019 | Updated: 14:15 BST, 19 April 2019
A fourth round of blood pressure pills have been recalled over fears they may contain carcinogens.
The move is part of an ongoing scramble to weed out drugs made in China and India, and dispatched across the world, that were contaminated with NMBA, NMDA, and NDEA - all potential cancer-causing chemicals.
The scandal was kept under wraps for a year before health officials finally acknowledged the contamination - and that more than two million people had been exposed.
Once it broke, it prompted a global shortage of the most commonly used blood pressure drugs - valsartan, irbesartan and losartan - that is still dragging on almost a year
read more from dailymail.....
Tags
fashion
wedding
dress
style
tv mount
Amazon
news
lifestyle
Celebrity News
Kim Kardashian
vichy
neal's yard
aubrey organics
neal's yard remedies
babo botanicals
kiehls store
the body
american auto insurance
auto policy quote
auto quotes online
instant car insurance quote
buy car insurance online